Navigation Links
Alfacell's ONCONASE(R) Shows Potential as Radiation Sensitizer for Lung Cancer Treatment
Date:4/14/2008

Poster Presented at the 2008 AACR Annual Meeting

SOMERSET, N.J., April 14 /PRNewswire-FirstCall/ -- Alfacell Corporation (Nasdaq: ACEL) today announced that Dr. Intae Lee with the University of Pennsylvania has reported that Alfacell's ONCONASE (ranpirnase) could be a promising radiation sensitizer for lung cancer treatment. Dr. Lee presented the pre-clinical in vivo and in vitro data in a poster at the 2008 American Association of Cancer Research (AACR) Annual Meeting being held April 12 - 16 in San Diego.

In the poster titled "The inhibition of radiation repair by ranpirnase +/- I-buthionine sulfoximide on lung cancer," Dr. Lee provided pre-clinical evidence that ONCONASE +/- I-buthionine sulfoximide significantly increased the radiation-induced growth delay of lung tumors in vivo without increases in skin reaction, compared to radiation alone. Additionally, in vivo and in vitro data presented indicated that ONCONASE significantly increased apoptosis (programmed cell death) in several human non-small cell lung cancer (NSCLC) cell lines (A549, NCI-H1975 and HOP-62). Dr. Lee and his team of researchers also showed that the radiation repair mechanisms known as sub-lethal damage repair (SLDR) and potentially lethal damage repair (PLDR), which lead to radiation resistance in tumors, were significantly inhibited by ONCONASE in vitro.

"Our research suggests potential utility of ONCONASE as a radiotherapy enhancer for the treatment of NSCLC patients," said Dr. Lee. "It is important to overcome PLDR as it can ultimately lead to radiation resistance. One of our key findings is the inhibiting impact of ONCONASE on the PLDR mechanism, which is a pre-requisite to developing a radiotherapy enhancer."

Kuslima Shog
'/>"/>

SOURCE Alfacell Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
2. Alfacell Updates Status of ONCONASE(R) Phase III Clinical Program
3. Alfacell Updates Status of ONCONASE(R) Phase III Clinical Program
4. Pre-Clinical Data Show Intracellular Pathways Affected by ONCONASE(R)
5. Iomai Trial Shows 100 Percent Immune Response in Elderly Subjects Vaccinated With Novel Travelers Diarrhea Patch Vaccine
6. Study Shows Combination Therapy Incorporating AVODART(R) and Tamsulosin Provides Continuous Symptom Improvement Over 2 Years
7. Largest Study to Date Shows Significant Reductions in Risks of Blood Clots and Reintervention With CYPHER(R) Sirolimus-eluting Coronary Stent Compared to Taxus Stent
8. Kosans Second-Generation Hsp90 Inhibitor, Alvespimycin, Shows 42% Clinical Benefit in Phase 1 HER2-Positive Metastatic Breast Cancer Trial
9. Study Shows Plasma-Derived Human Thrombin Equivalent to Bovine Thrombin in Achieving Hemostasis in Surgery
10. Cleveland Clinic Study Shows the Diabetes Drug Pioglitazone Reduces Risk of Death, Heart Attack and Stroke, but Increases Risk of Heart Failure
11. New Data From Large Safety Analysis of MYCAMINE Shows Favorable Clinical Safety Profile
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... , June 2, 2015   PDI , ... today announced a series of corporate commitments designed ... to reduce the threat of antimicrobial-resistant microorganisms as ... Centers for Disease Control and Prevention (CDC) and ... to Combat Antibiotic-Resistant Bacteria. Along with ...
(Date:6/2/2015)... 02, 2015 Research and Markets ( ... PharmaBiotech,s new report "Drug Delivery in Central ... to their offering. The delivery ... a challenge in the treatment of neurological disorders. ... or administered systematically (e.g., by intravenous injection) for ...
(Date:6/2/2015)... , June 2, 2015 The Canadian Society ... of specific tests, treatments or procedures that are ... Surgery as part of Choosing Wisely Canada.  The ... can support conversations between patients and physicians about ... Canadian Society for Vascular Surgery,s list identified the ...
Breaking Medicine Technology:PDI Partners with White House and Centers for Disease Control and Prevention (CDC) to Combat Antimicrobial Resistance 2Global Drug Delivery in Central Nervous System Diseases Report 2015-2024 - Technologies, Markets and Companies 2Global Drug Delivery in Central Nervous System Diseases Report 2015-2024 - Technologies, Markets and Companies 3As part of the Choosing Wisely Canada campaign the Canadian Society for Vascular Surgery releases list of commonly used tests and treatments to question 2As part of the Choosing Wisely Canada campaign the Canadian Society for Vascular Surgery releases list of commonly used tests and treatments to question 3As part of the Choosing Wisely Canada campaign the Canadian Society for Vascular Surgery releases list of commonly used tests and treatments to question 4
... from PI-88 in Liver Cancer and ... Highlight the Year -, SYDNEY, Australia, Aug. 23 ... for the fiscal year ended 30 June 2007. Fiscal ... Phase 2, 172 patient, post-resection liver cancer trial for ...
... Incorporated (Nasdaq:,VICL) announced today that results from a ... a plasmid DNA (pDNA) vaccine developed by the ... previously,reported Phase 1 conclusions that a "DNA prime-adenoviral ... was effective in inducing,T-cell immune responses in up ...
Cached Medicine Technology:Progen Pharmaceuticals Announces Fiscal 2007 Financial Results 2Progen Pharmaceuticals Announces Fiscal 2007 Financial Results 3Multiple NIH Phase 2 HIV Vaccine Trials Using Vical's Technology Produce Encouraging Results 2Multiple NIH Phase 2 HIV Vaccine Trials Using Vical's Technology Produce Encouraging Results 3
(Date:6/2/2015)... June 02, 2015 The Down Syndrome ... Potter from the hit show Glee as the keynote ... Walk in Pleasant Prairie, WI. The event aims to ... in Racine, Kenosha, and Walworth counties. ... join us for this important event," says Dawn Nuoffer, ...
(Date:6/2/2015)... (PRWEB) June 02, 2015 The ... replacement lawsuit ( http://www.consumerinjurylawyers.com/wright-profemur-hip-replacement ) is now underway ... to court documents, opening statements were presented on ... laser etchings on the Profemur hip replacement made ... it to snap just three years after it ...
(Date:6/2/2015)... (PRWEB) June 02, 2015 Tronics, a ... deploying its growth strategy to benefit from the significant ... Yole Développement’s May 2015 Status of the MEMS Industry ... sharply and reach $6.6B in 2020,” says Frederic Breussin, ... Développement . , The analyst adds that “although the ...
(Date:6/2/2015)... June 02, 2015 ANT Wireless, proven ... market entry of two new products implementing the ANT+ ... announce new wireless interoperability in their bike trainer products, ... cyclists. Tacx has implemented the FE-C device profile in ... well as its new indoor training software, while Kinomap ...
(Date:6/2/2015)... Acara Partners has seen a spike in ... mobile devices, as is now required by recent Google search ... well as several new clients in the medical aesthetics vertical, ... them to meet Google’s new requirements,” commented Fran Acunzo, CEO ... clients in education, non-profits, and the business world.” , ...
Breaking Medicine News(10 mins):Health News:Glee star Lauren Potter helps Down Syndrome Association of WI raise awareness, support 2Health News:First of More Than 1,200 Wright Hip Lawsuits Goes to Trial in California Superior Court 2Health News:First of More Than 1,200 Wright Hip Lawsuits Goes to Trial in California Superior Court 3Health News:Tronics Aims to Benefit from Major Growth of Sensors and Related Technologies for Healthcare Applications 2Health News:First ANT FE-C Enabled Fitness Products Enter Market 2Health News:First ANT FE-C Enabled Fitness Products Enter Market 3Health News:Acara Partners Expands Website and Digital Offerings 2
... University is investigating the molecular composition of cataracts in ... reverse the eye disease. Cataracts, a clouding of ... in the world, according to the National Institutes of ... eye lens is the only recommended method for restoring ...
... July 14 The Empire State Healthcare Coalition expresses its ... national, government-run health plan to compete with private insurers. ... eliminate free market efficiency and reduce healthcare quality. , ... (the "Coalition") is not-for-profit organization formed by New York State ...
... ... the Pederson Immigration Law Group, P.C. is slated to be keynote speaker at this ... ... - The Pederson Immigration Law Group, P.C., (PILG) announced that Jan Pederson, the nation,s ...
... published in the July issue of the Journal of ... with gastrointestinal stromal tumors (GIST), a rare cancer that begins ... rates equivalent to those of Caucasians. Prior to 2000, African ... to undergo surgical treatment for this type of cancer. ...
... , KUALA LUMPUR, Malaysia, July 14 Ramuan ... from ancient Malaysian culture, will be revealed to a global audience ... new book, Health and Beauty from the Rainforest: Malaysian Traditions ... by these traditions. A lifestyle approach to wellness, ramuan ...
... , , MINNEAPOLIS, July 14 ... advised Biotel that it is terminating the Merger Agreement with ... terms of the agreement. Biotel believes it has complied with ... merit and inconsistent with CardioNet,s representations to Biotel. Biotel is ...
Cached Medicine News:Health News:K-State scientist receives grant from National Institutes of Health to research cataracts 2Health News:The Empire State Healthcare Coalition Voices Concern Over the Affordable Health Choices Act 2Health News:Pederson Immigration Law Group Attorneys Featured in 14th Annual J-1/H-1B Foreign Physician Immigration Conference and Job Fair Series 2Health News:Pederson Immigration Law Group Attorneys Featured in 14th Annual J-1/H-1B Foreign Physician Immigration Conference and Job Fair Series 3Health News:Study finds survival rates from gastrointestinal tumors improving among African-Americans 2Health News:U.S. Debut: Holistic Health And Beauty From The Rainforest - New Book Reveals Closely Guarded Malaysian Health and Beauty Secrets Introducing the World to Time-Honored Tradition of Ramuan 2Health News:U.S. Debut: Holistic Health And Beauty From The Rainforest - New Book Reveals Closely Guarded Malaysian Health and Beauty Secrets Introducing the World to Time-Honored Tradition of Ramuan 3
The Oculus easyfield is an exciting new compact perimeter to do automatic static perimetry up to 30 degrees eccentricity. It has been designed for the combined use as a visual field screener and peri...
... accurate detections of any ... as glaucoma in the ... performed. Smooth operation of ... High accuracy of static ...
... in visual field testing that's so efficient it ... the first visual field instrument that's simple enough, ... even in pre-test. Affordably priced FDT has years ... validate performance. The instrument produce screening results in ...
... The Humphrey Matrix represents the ... Using frequency doubling technology, the Humphrey ... thorough visual field evaluation and assess ... enables you to provide complete long-term ...
Medicine Products: